Literature DB >> 20033368

Immunohistochemical analyses of E-cadherin, beta-catenin, CD44s, and CD44v6 expressions, and Ki-67 labeling index in intraductal papillary mucinous neoplasms of the pancreas and associated invasive carcinomas.

Akira Okimura1, Hiroshi Hirano, Takashi Nishigami, Shigemitsu Ueyama, Shiro Tachibana, Yoshikazu Fukuda, Koji Yamanegi, Hideki Ohyama, Nobuyuki Terada, Keiji Nakasho.   

Abstract

We examined the expressions of adhesion molecules (E-cadherin, beta-catenin, CD44s, and CD44v6) and Ki-67 labeling index (Ki-67 LI) in low- and moderate-grade dysplasia and invasive carcinoma components in ten noninvasive intraductal papillary mucinous neoplasms (IPMNs) of the pancreas and eight invasive carcinomas associated with IPMNs of the pancreas using immunohistochemical methods. There was no significant difference in regard to the proportion of components expressing either E-cadherin or beta-catenin in more than 70% of the tumor cells between the low- and moderate-grade dysplasia components. In contrast, the proportion of those in invasive carcinoma components was significantly lower than in low- or moderate-grade dysplasia components. Also, there was no significant difference in the proportion of components expressing CD44s or CD44v6 in more than 5% of tumor cells among low-grade dysplasia, moderate-grade dysplasia, and invasive carcinoma components. In contrast, the Ki-67 LI values increased in the order of low-grade dysplasia, moderate-grade dysplasia, and invasive carcinoma components, with significant differences among them. The present results indicate that carcinoma components are associated with a decrease in tumor cells expressing E-cadherin and beta-catenin and have the highest proliferative activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033368     DOI: 10.1007/s00795-009-0462-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  19 in total

1.  Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.

Authors:  N Gunji; T Oda; T Todoroki; N Kanazawa; T Kawamoto; K Yuzawa; A Scarpa; K Fukao
Journal:  Cancer       Date:  1998-05-01       Impact factor: 6.860

2.  Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.

Authors:  Runjan Chetty; Stefano Serra; Sima Salahshor; Khaled Alsaad; Warren Shih; Hagen Blaszyk; James R Woodgett; Ming-Sound Tsao
Journal:  Hum Pathol       Date:  2006-02       Impact factor: 3.466

3.  Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study.

Authors:  E M Castellà; A Ariza; I Ojanguren; J L Mate; X Roca; A Fernández-Vasalo; J J Navas-Palacios
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

4.  Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome.

Authors:  Ichiro Watanabe; Takahiro Hasebe; Satoshi Sasaki; Masaru Konishi; Kazuto Inoue; Toshio Nakagohri; Tatsuya Oda; Kiyoshi Mukai; Taira Kinoshita
Journal:  Pancreas       Date:  2003-05       Impact factor: 3.327

Review 5.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.

Authors:  Cristina Faleiro-Rodrigues; Isabel Macedo-Pinto; Deolinda Pereira; Veronica M Ferreira; Carlos S Lopes
Journal:  Hum Pathol       Date:  2004-06       Impact factor: 3.466

Review 7.  E-cadherin mediated adhesion system in cancer cells.

Authors:  H Shiozaki; H Oka; M Inoue; S Tamura; M Monden
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

8.  Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.

Authors:  M Pignatelli; T W Ansari; P Gunter; D Liu; S Hirano; M Takeichi; G Klöppel; N R Lemoine
Journal:  J Pathol       Date:  1994-12       Impact factor: 7.996

9.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

10.  Expression of CD44 variants and its association with survival in pancreatic cancer.

Authors:  T Gotoda; Y Matsumura; H Kondo; D Saitoh; Y Shimada; T Kosuge; Y Kanai; T Kakizoe
Journal:  Jpn J Cancer Res       Date:  1998-10
View more
  3 in total

1.  Malignant mesothelioma of the peritoneum: case reports and immunohistochemical findings including Ki-67 expression.

Authors:  Hiroshi Hirano; Takashi Fujisawa; Koichi Maekawa; Eriko Ohkubo; Akira Okimura; Kozo Kuribayashi; Takashi Nakano; Keiji Nakasho; Takashi Nishigami
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

2.  MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm.

Authors:  Tatsuo Shimura; Yasuhide Kofunato; Ryo Okada; Rei Yashima; Koji Okada; Kenichiro Araki; Yasuo Hosouchi; Hiroyuki Kuwano; Seiichi Takenoshita
Journal:  Mol Clin Oncol       Date:  2016-05-20

3.  EMT and dissemination precede pancreatic tumor formation.

Authors:  Andrew D Rhim; Emily T Mirek; Nicole M Aiello; Anirban Maitra; Jennifer M Bailey; Florencia McAllister; Maximilian Reichert; Gregory L Beatty; Anil K Rustgi; Robert H Vonderheide; Steven D Leach; Ben Z Stanger
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.